CAS: 13534-90-2; 3,4-Dibromopyridine

该化合物是一种杂交有机化合物,其特征是3和4个位置上用2个溴原子替换的环,其分子式为C5H3BR2N,其特征是芳香环内氮原子,有助于其基本性和反应性.该化合物一般是无色的,根据温度和纯度而呈现为黄色液体或固体色素;以有机溶剂中的中溶解度和水溶性有限而著称.3,4-二溴丙烯在各种化学合成中使用,特别是在制药业和农用化学工业中,作为生产更复杂的分子的中间体.溴原子的存在增强了其电子生物特性,使它成为诸如核生殖器替代和混合反应等反应中的有用建筑块.在处理该化合物时,应注意安全防范措施,因为如果吸入或吸入,可能会对健康造成危害,因此应采取适当保护措施来减轻接触.

英文名称3,4-Dibromopyridine
中文名称3,4-二溴吡啶
IUPAC名称3,4-dibromopyridine
其它别名3,4-Dibromopyridine
CAS编号13534-90-2
MFCD编号:MFCD00234016
EINECS号:800-799-3
分子式:C5H3Br2N
分子量:236.89
产品CID: 541972
产品分类有机原料→分子砌块→芳杂环类化合物→吡啶类化合物

相似结构搜索
产品信息参考;
InChIKey: ZFZWZGANFCWADD-UHFFFAOYSA-N
InChI=1S/C5H3Br2N/c6-4-1-2-8-3-5(4)7/h1-3H…
计算化学: 氢键受体数1.0氢键供体数0.0可旋转键数0.0

相似化合物

626-55-1 625-92-3 13534-89-9

MSDS等安全信息

GHS象形图
GHS符号GHS07;
注释: Exclamation mark
危险类别皮肤腐蚀/刺激类别2
严重眼刺激类别2
急性毒性类别4(经口)
特定目标器官毒性 - 单次接触类别3
严重眼刺激类别2A
警示词Warning(警告)
危险描述H315 |造成皮肤刺激.
H319 |造成严重眼刺激.
H302 |吞咽有害.
H335 |可能引起呼吸道刺激.
防范说明P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
危险等级IRRITANT
危险品标志Xi
安全声明26-36
危险类别码36/37/38

欧盟法规

C&L通报

上下游产品

合成工艺路线路线简述

吡啶置于溴体系中,化学反应生成3,4-二溴吡啶
参考文献:Den Hertog,Recueil Des Travaux Chimiques Des Pays-Bas,1945,Vol. 64,P. 85,98
标题:Den Hertog,Recueil Des Travaux Chimiques Des Pays-Bas,1945,Vol. 64,P. 85,98

海关参考信息

2933310010-吡啶
2939800000-其他生物碱
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-7884125-B2
优先权日:2008-04-30
标题:Straightforward entry to 7-azabicyclo[2.2.1]heptane-1-carbonitriles and subsequent synthesis of epibatidine analogues
发明人：STEVENS CHRISTIAN; HEUGEBAERT THOMAS
权利人:UNIV GENT
摘要:The present invention relates to a group of substituted-7-azabicyclo-[2.2.1]heptyl derivatives with biological activity. The present invention also relates to synthetic methods for producing said substituted-7-azabicyclo-[2.2.1]heptyl derivatives. The present invention also relates to certain intermediates for producing such substituted-7-azabicyclo-[2.2.1]heptyl derivatives, as well as a synthetic method for producing such intermediates. The present invention also relates to pharmaceutical compositions comprising such substituted-7-azabicyclo-[2.2.1]heptyl derivatives, as well as their use as medicaments for the treatment of diseases mediated by a Nicotinic Acetylcholine Receptor or a receptor being a member of the Neurotransmitter-gated Ion Channel Superfamily, such as pain, Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy and nicotine addiction.

专利号:US-2009275616-A1
优先权日:2008-04-30
标题 :Straightforward entry to 7-azabicyclo[2.2.1]heptane-1-carbonitriles and subsequent synthesis of epibatidine analogues